Common variants in WFS1 confer risk of type 2 diabetes (original) (raw)
References
- Gloyn, A.L. et al. Diabetes 52, 568–572 (2003).
Article CAS Google Scholar - Nielsen, E.M. et al. Diabetes 52, 573–577 (2003).
Article CAS Google Scholar - Silander, K. et al. Diabetes 53, 1141–1149 (2004).
Article CAS Google Scholar - Love-Gregory, L.D. et al. Diabetes 53, 1134–1140 (2004).
Article CAS Google Scholar - Grant, S.F. et al. Nat. Genet. 38, 320–323 (2006).
Article CAS Google Scholar - Minton, J.A. et al. Diabetes 51, 1287–1290 (2002).
Article CAS Google Scholar - Inoue, H. et al. Nat. Genet. 20, 143–148 (1998).
Article CAS Google Scholar - Strom, T.M. et al. Hum. Mol. Genet. 7, 2021–2028 (1998).
Article CAS Google Scholar - Riggs, A.C. et al. Diabetologia 48, 2313–2321 (2005).
Article CAS Google Scholar - Ishihara, H. et al. Hum. Mol. Genet. 13, 1159–1170 (2004).
Article CAS Google Scholar - Karasik, A. et al. Diabetes Care 12, 135–138 (1989).
Article CAS Google Scholar - Yamada, T. et al. Hum. Mol. Genet. 15, 1600–1609 (2006).
Article CAS Google Scholar - Ozcan, U. et al. Science. 313, 1137–1140 (2006).
Article Google Scholar - Altshuler, D. et al. Nat. Genet. 26, 76–80 (2000).
Article CAS Google Scholar
Acknowledgements
We thank all study participants. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council (MRC) grant G0000934 and the Wellcome Trust grant 068545/Z/02. The Ashkenazi population was collected by the Israeli Diabetes Research Group, funded by the Russell Berrie Foundation, D-Cure, Diabetes Care in Israel, Israel Ministry of Health and an unrestricted research grant from Novo-Nordisk. The Wellcome Trust and Diabetes UK funded the Warren 2 study. The work on the Cambridgeshire case-control, Ely, ADDITION and EPIC-Norfolk studies was funded by support from the Wellcome Trust and MRC. We are grateful to S. Griffin, MRC Epidemiology Unit for assistance with the ADDITION study and to S. O'Rahilly and M. Sampson for their contribution to the Warren 2 study. The UK type 2 diabetes case/control collection (Go-DARTS2) was funded by the Wellcome Trust. C.N.A.P. and A.D.M. are supported by the Scottish Executive Chief Scientist's Office as part of the Generation Scotland initiative. Illumina genotyping was done by P. Deloukas's laboratory at the Wellcome Trust Sanger Institute. I. Blech. and K.A.F. are funded by the Wellcome Trust. I.B. acknowledges support from EU FP6 funding (contract number LSHM-CT-2003-503041). A.T.H. is a Wellcome Trust Research Leave Fellow. M.N.W. is a Vandervell Foundation Research Fellow. S.L.D. is funded by the British Heart Foundation. None of the sponsors or funders had any role in the design and conduct of the study, in the collection, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.
Author information
Author notes
- Manjinder S Sandhu and Michael N Weedon: These authors contributed equally to this work.
Authors and Affiliations
- UK Medical Research Council (MRC) Epidemiology Unit, Strangeways Research Laboratory, Cambridge, CB1 8RN, UK
Manjinder S Sandhu & Nicholas J Wareham - Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, CB2 0SR, UK
Manjinder S Sandhu & Sally L Debenham - Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, EX1 2LU, UK
Michael N Weedon, Hana Lango, Timothy M Frayling & Andrew T Hattersley - Metabolic Disease Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK
Katherine A Fawcett, Allan Daly & Inês Barroso - Washington University School of Medicine, St. Louis, 63110, Missouri, USA
Jon Wasson, Rosalind J Neumann, Richard Sherva & M Alan Permutt - Endocrine and Metabolism Service, The Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel
Ilana Blech & Benjamin Glaser - Cancer Research UK Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK
Paul D Pharoah - Population Pharmacogenetics Group, Biomedical Research Centre, University of Dundee, Dundee, DD1 9SY, UK
Colin N A Palmer, Charlotte Kimber & Roger Tavendale - Division of Medicine and Therapeutics, Diabetes Research Group, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
Andrew D Morris - Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, OX3 7LJ, UK
Mark I McCarthy - Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK
Mark I McCarthy - Diabetes Research Group, School of Clinical Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
Mark Walker - Centre for Diabetes and Metabolic Medicine, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London, E1 1BB, UK
Graham Hitman
Authors
- Manjinder S Sandhu
You can also search for this author inPubMed Google Scholar - Michael N Weedon
You can also search for this author inPubMed Google Scholar - Katherine A Fawcett
You can also search for this author inPubMed Google Scholar - Jon Wasson
You can also search for this author inPubMed Google Scholar - Sally L Debenham
You can also search for this author inPubMed Google Scholar - Allan Daly
You can also search for this author inPubMed Google Scholar - Hana Lango
You can also search for this author inPubMed Google Scholar - Timothy M Frayling
You can also search for this author inPubMed Google Scholar - Rosalind J Neumann
You can also search for this author inPubMed Google Scholar - Richard Sherva
You can also search for this author inPubMed Google Scholar - Ilana Blech
You can also search for this author inPubMed Google Scholar - Paul D Pharoah
You can also search for this author inPubMed Google Scholar - Colin N A Palmer
You can also search for this author inPubMed Google Scholar - Charlotte Kimber
You can also search for this author inPubMed Google Scholar - Roger Tavendale
You can also search for this author inPubMed Google Scholar - Andrew D Morris
You can also search for this author inPubMed Google Scholar - Mark I McCarthy
You can also search for this author inPubMed Google Scholar - Mark Walker
You can also search for this author inPubMed Google Scholar - Graham Hitman
You can also search for this author inPubMed Google Scholar - Benjamin Glaser
You can also search for this author inPubMed Google Scholar - M Alan Permutt
You can also search for this author inPubMed Google Scholar - Andrew T Hattersley
You can also search for this author inPubMed Google Scholar - Nicholas J Wareham
You can also search for this author inPubMed Google Scholar - Inês Barroso
You can also search for this author inPubMed Google Scholar
Contributions
I. Barroso, A.T.H., M.A.P., N.J.W. and M.S.S. designed this study; M.S.S. did the statistical analysis, supported by I. Barroso, A.D., S.L.D., K.A.F., H.L., R.J.N., P.D.P., R.S. and M.N.W. M.S.S. wrote the manuscript with I. Barroso, S.L.D. and K.A.F.; A.D. conducted the bioinformatic analysis; I. Blech., S.L.D., K.A.F. and C.K. arrayed and genotyped the replication studies; B.G., A.T.H., G.H., C.K., A.D.M., M.I.M., C.N.A.P., M.W., R.T., J.W. and N.J.W. provided study samples and all authors contributed to data interpretation and commented on the final manuscript.
Corresponding authors
Correspondence toManjinder S Sandhu or Inês Barroso.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Sandhu, M., Weedon, M., Fawcett, K. et al. Common variants in WFS1 confer risk of type 2 diabetes.Nat Genet 39, 951–953 (2007). https://doi.org/10.1038/ng2067
- Received: 07 February 2007
- Accepted: 17 May 2007
- Published: 01 July 2007
- Issue Date: August 2007
- DOI: https://doi.org/10.1038/ng2067